Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
664.60    1.60 (0.24%)
Bid:
664.60
Ask:
664.80
Spread: 0.20 (0.03%)
Market Cap: £52.90b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Directorate Change

16 Dec 2022 09:33

RNS Number : 9997J
NatWest Group plc
16 December 2022
 

16 December 2022

NatWest Group plc

Directorate change

 

NatWest Group plc ('NWG') announces that Stuart Lewis will be appointed as an independent non-executive director and member of the Group Board Risk Committee on 1 April 2023. Subject to regulatory approval, Stuart Lewis will be appointed as Chairman of the Group Board Risk Committee ('BRC') on 1 August 2023.

 

Morten Friis has confirmed his intention to step down as a non-executive director with effect from the close of business on 31 July 2023. Morten will reach the 9 year point in his tenure on 1 April 2023, but has agreed to remain on the Board for an additional period to allow for an orderly handover of responsibilities to Stuart Lewis.

Howard Davies, Chairman of NWG, said:

"I would like to thank Morten for his commitment, diligence and immense contribution since joining as a non-executive director in 2014. He has approached the role of BRC Chair with great skill and care and we have benefitted significantly from his expertise and wise counsel. My Board colleagues and I wish him well for the future. 

I am delighted that Stuart is joining the Board as a non-executive director in April, in advance of taking on the BRC Chair role, subject to regulatory approval. Stuart will bring extensive risk management and financial services experience to the Board, having spent the majority of his executive career with Deutsche Bank, most recently as Group Chief Risk Officer and a member of the management board of Deutsche Bank AG." 

There are no further matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

NatWest Group Investor Relations:

Alexander Holcroft

Head of Investor Relations

+44 (0) 20 7672 1758

 

NatWest Group Media Relations:

+44 (0) 131 523 4205

 

LEI: 2138005O9XJIJN4JPN90

Stuart Lewis Biography

Stuart Lewis served 10 years on the Management Board of Deutsche Bank as Chief Risk Officer, retiring in May 2022. Since joining Deutsche Bank in 1996, he held senior roles including Deputy Chief Risk Officer, Global Chief Credit Officer and Chief Credit Officer for Asia Pacific. He was previously Head of European Credit Risk Management at Credit Suisse Financial Products. In 2013, Stuart was elected to the Global Association of Risk Professionals (GARP) Board of Trustees. He was also a Member of the Foundation Board of the International Financial Risk Institute (IFRI) and served as Chair from 2016 to 2018. Stuart is a visiting Professor in Practice in the Finance Department of the London School of Economics (LSE). Stuart attended the University of Dundee where he obtained an LLB (Hons). He also holds a LLM (Merit) from the London School of Economics and took the Law Society finals examinations at the College of Law, Guildford.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKQLBFLLLXFBF
Date   Source Headline
3rd Jan 20244:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202410:38 amRNSHolding(s) in Company
2nd Jan 20245:24 pmRNSTransaction in Own Shares
29th Dec 202312:47 pmRNSTotal Voting Rights
29th Dec 202310:30 amRNSDirector/PDMR Shareholding
28th Dec 20235:37 pmRNSTransaction in Own Shares
27th Dec 20235:18 pmRNSTransaction in Own Shares
22nd Dec 20231:27 pmRNSTransaction in Own Shares
21st Dec 20235:23 pmRNSTransaction in Own Shares
20th Dec 20235:35 pmRNSTransaction in Own Shares
19th Dec 20235:33 pmRNSTransaction in Own Shares
19th Dec 20233:00 pmRNSDirector/PDMR Shareholding
18th Dec 20235:31 pmRNSTransaction in Own Shares
15th Dec 20235:25 pmRNSTransaction in Own Shares
15th Dec 20239:00 amRNSKey findings from Phase 2 of Travers Smith review
13th Dec 20235:32 pmRNSTransaction in Own Shares
12th Dec 20235:29 pmRNSTransaction in Own Shares
11th Dec 20239:38 amRNSHolding(s) in Company
8th Dec 20239:46 amRNSPublication of a Prospectus
7th Dec 20235:18 pmRNSTransaction in Own Shares
6th Dec 20235:30 pmRNSTransaction in Own Shares
5th Dec 20235:07 pmRNSTransaction in Own Shares
4th Dec 20235:12 pmRNSTransaction in Own Shares
1st Dec 20235:41 pmRNSTransaction in Own Shares
1st Dec 20239:52 amRNSTotal Voting Rights
29th Nov 20235:57 pmRNSTransaction in Own Shares
28th Nov 20235:31 pmRNSTransaction in Own Shares
27th Nov 20235:35 pmRNSTransaction in Own Shares
24th Nov 20235:34 pmRNSTransaction in Own Shares
23rd Nov 20235:27 pmRNSTransaction in Own Shares
23rd Nov 20233:39 pmRNSDividend Declaration
22nd Nov 20235:39 pmRNSTransaction in Own Shares
22nd Nov 20238:30 amRNSJPMorgan UK Leaders Conference
21st Nov 20235:54 pmRNSTransaction in Own Shares
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
20th Nov 20235:09 pmRNSTransaction in Own Shares
16th Nov 20235:33 pmRNSTransaction in Own Shares
14th Nov 20235:36 pmRNSTransaction in Own Shares
13th Nov 20235:04 pmRNSTransaction in Own Shares
13th Nov 20237:00 amRNSQ3 2023 Pillar 3
10th Nov 20235:06 pmRNSTransaction in Own Shares
10th Nov 20239:30 amRNSSection 430 (2B) Companies Act 2006 Statement
9th Nov 20235:05 pmRNSTransaction in Own Shares
9th Nov 20232:00 pmRNSDirector/PDMR Shareholding
8th Nov 20235:14 pmRNSTransaction in Own Shares
6th Nov 20235:17 pmRNSTransaction in Own Shares
3rd Nov 20236:02 pmRNSTransaction in Own Shares
2nd Nov 20235:13 pmRNSTransaction in Own Shares
1st Nov 20235:38 pmRNSTransaction in Own Shares
31st Oct 20236:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.